| 15658576
|
Operative treatment of cervical premalignant lesions and the presence of high-risk human papilloma virus as etiologic agent. |
Bratisl Lek Listy |
2004 |
Milanova E;Naumov J;Stojovski M;Todorovska I;Daneva K |
View
More |
| 179319
|
Selection of cell culture systems for virus isolation. |
Am J Med Technol |
1976 |
Cooney MK |
View
More |
| 20976136
|
Skin vaccination against cervical cancer associated human papillomavirus with a novel micro-projection array in a mouse model. |
PLoS One |
2010 |
Corbett HJ;Fernando GJ;Chen X;Frazer IH;Kendall MA |
View
More |
| 24022639
|
Human papillomavirus: current status and issues of vaccination. |
Arch Virol |
2014 |
Malik H;Khan FH;Ahsan H |
View
More |
| 2547810
|
Filter in situ hybridisation: an evaluation of the FISH technique for HPV detection in cervical swabs. |
J Virol Methods |
1989 |
Hording U;Sebbelov A;Daugaard S;Bock JE;Norrild B |
View
More |
| 29449668
|
Rhinovirus 3C protease suppresses apoptosis and triggers caspase-independent cell death. |
Cell Death Dis |
2018 |
Lotzerich M;Roulin PS;Boucke K;Witte R;Georgiev O;Greber UF |
View
More |
| 33553082
|
Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation. |
Front Public Health |
2020 |
Kombe Kombe AJ;Li B;Zahid A;Mengist HM;Bounda GA;Zhou Y;Jin T |
View
More |
| 34429079
|
HPV-specific risk assessment of cervical cytological abnormalities. |
BMC Cancer |
2021 |
Zhong G;Wang Y;Xie Q;Lin R;Yao T |
View
More |
| 37840437
|
MRI-based radiomic signatures for pretreatment prognostication in cervical cancer. |
Cancer Med |
2023 |
Wagner-Larsen KS;Hodneland E;Fasmer KE;Lura N;Woie K;Bertelsen BI;Salvesen O;Halle MK;Smit N;Krakstad C;Haldorsen IS |
View
More |
| 4334577
|
[The effect of pancreatin on rhinovirus multiplication and plaque formation]. |
Vopr Virusol |
1969 |
Konstantinova LA;Stakhanova VM |
View
More |
